Freeman,grieve Limited

POWER SEARCH PRICING

SOLUTIONS

freeman,grieve limited Company Information

Company Number

00370363

Next Accounts

76 days late

Directors

Neal Radia

Shareholders

radipharm limited

Group Structure

View All

Industry

Dispensing chemist in specialised stores

Registered Address

2 burton house repton place,, white lion road, amersham, HP7 9LP

Website

derekspharmacy.co.uk

freeman,grieve limited Estimated Valuation

£1.9m

Pomanda estimates the enterprise value of FREEMAN,GRIEVE LIMITED at £1.9m based on Net Assets of £900.8k and 2.09x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Freeman,grieve Limited is a live company located in amersham, HP7 9LP with a Companies House number of 00370363. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in October 1941, it's largest shareholder is radipharm limited with a 100% stake. Freeman,grieve Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.6m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Freeman,Grieve Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating2out of 5

1 Strong

3 Regular

7 Weak

Size

annual sales of £3.6m, make it smaller than the average company (£12m)

Growth

3 year (CAGR) sales growth of -2%, show it is growing at a slower rate (5.9%)

EXPORT

Freeman,Grieve Limited's latest turnover from April 2023 is estimated at £3.6 million and the company has net assets of £900.8 thousand. According to their latest financial statements, Freeman,Grieve Limited has 11 employees and maintains cash reserves of £1.3 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Turnover	3,564,217	6,137,946	4,795,586	3,764,339	2,400,944	1,244,426	807,341	1,262,401	1,174,626	1,434,551	1,560,868	1,605,602	1,631,536	1,583,359
Other Income Or Grants
Cost Of Sales	2,397,505	4,083,691	3,261,068	2,601,069	1,642,973	841,042	547,467	879,775	853,010	966,894	1,084,883	1,131,626	1,157,094	1,121,517
Gross Profit	1,166,712	2,054,255	1,534,518	1,163,271	757,971	403,384	259,874	382,626	321,616	467,657	475,985	473,976	474,442	461,842
Admin Expenses	1,172,290	1,725,906	964,622	886,575	711,162	329,082	285,904	343,275	327,665	390,593	453,299	449,442	458,868	459,116
Operating Profit	-5,578	328,349	569,896	276,696	46,809	74,302	-26,030	39,351	-6,049	77,064	22,686	24,534	15,574	2,726
Interest Payable	78,163	59,370	59,462	30,403				45,174	41,378	30,072	24,440	25,410	18,010	9,330
Interest Receivable	10,063	4,212	469	160	512	653	1,029	1,082		343	289	294	258	202
Pre-Tax Profit	-73,677	273,190	510,904	246,453	47,321	74,954	-25,001	-4,741	-47,427	47,335	-1,465	-582	-2,178	-6,402
Tax		-51,906	-97,072	-46,826	-8,991	-14,241		-14,141	1,087	-10,119		-4,472	3,092	-987
Profit After Tax	-73,677	221,284	413,832	199,627	38,330	60,713	-25,001	-18,882	-46,340	37,216	-1,465	-5,054	914	-7,389
Dividends Paid								25,000	25,000	35,300
Retained Profit	-73,677	221,284	413,832	199,627	38,330	60,713	-25,001	-43,882	-71,340	1,916	-1,465	-5,054	914	-7,389
Employee Costs	277,666	562,730	682,617	354,910	251,161	141,103	111,267	104,563	173,307	223,961	219,385	218,236	219,758	201,281
Number Of Employees	11	24	31	17	12	7	6	6	10	13	13	13	13	12
EBITDA*	74,229	470,824	685,708	310,885	60,465	80,134	-25,314	40,190	-4,935	78,715	25,289	27,502	19,416	4,752

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Tangible Assets		134,014	159,738	162,801	176,457	70,145	1,037	1,753	2,592	3,706	3,883	6,485	9,453	5,568
Intangible Assets		970,034	1,045,912	1,117,638
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets		1,104,048	1,205,650	1,280,439	176,457	70,145	1,037	1,753	2,592	3,706	3,883	6,485	9,453	5,568
Stock & work in progress		216,104	231,755	216,952	114,802	68,133	47,476	55,178	50,195	45,220	52,040	51,619	56,000	55,500
Trade Debtors	614,236	963,794	674,333	628,815	395,898	192,324	174,507	259,648	240,739	250,872	228,763	246,435	257,903	243,247
Group Debtors	1,375,358	507,643	530,534	283,721
Misc Debtors	28,407	129,145	145,546	104,659	77,125	49,817		20,801	20,548	14,862	21,894	27,620	27,761	18,105
Cash	1,327	472,229	650,844	287,695	31,841	104,613	156,483	666,585	643,632	625,641	360,048	474,250	430,010	333,700
misc current assets
total current assets	2,019,328	2,288,915	2,233,012	1,521,842	619,666	414,887	378,466	1,002,212	955,114	936,595	662,745	799,924	771,674	650,552
total assets	2,019,328	3,392,963	3,438,662	2,802,281	796,123	485,032	379,503	1,003,965	957,706	940,301	666,628	806,409	781,127	656,120
Bank overdraft	100,734	95,628	145,628	92,328
Bank loan
Trade Creditors	198,199	977,448	947,510	855,092	387,089	250,127	48,734	924,144	65,587	62,634	79,135	97,043	113,313	106,070
Group/Directors Accounts					26,848	29,381			622,924	548,477		398,362
other short term finances
hp & lease commitments
other current liabilities	181,302	614,412	761,193	591,339	218,342	104,132	290,090		159,633	148,288	408,507	130,553	482,309	365,063
total current liabilities	480,235	1,687,488	1,854,331	1,538,759	632,279	383,640	338,824	924,144	848,144	759,399	487,642	625,958	595,622	471,133
loans	618,028	710,733	807,123	904,483
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions	20,277	20,277	24,027	23,220	24,122			14,141						396
total long term liabilities	638,305	731,010	831,150	927,703	24,122			14,141						396
total liabilities	1,118,540	2,418,498	2,685,481	2,466,462	656,401	383,640	338,824	938,285	848,144	759,399	487,642	625,958	595,622	471,529
net assets	900,788	974,465	753,181	335,819	139,722	101,392	40,679	65,680	109,562	180,902	178,986	180,451	185,505	184,591
total shareholders funds	900,788	974,465	753,181	335,819	139,722	101,392	40,679	65,680	109,562	180,902	178,986	180,451	185,505	184,591

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Operating Activities
Operating Profit	-5,578	328,349	569,896	276,696	46,809	74,302	-26,030	39,351	-6,049	77,064	22,686	24,534	15,574	2,726
Depreciation	41,868	66,597	39,934	13,656	13,656	5,832	716	839	1,114	1,651	2,603	2,968	3,842	2,026
Amortisation	37,939	75,878	75,878	20,533
Tax		-51,906	-97,072	-46,826	-8,991	-14,241		-14,141	1,087	-10,119		-4,472	3,092	-987
Stock	-216,104	-15,651	14,803	102,150	46,669	20,657	-7,702	4,983	4,975	-6,820	421	-4,381	500	55,500
Debtors	417,419	250,169	333,218	544,172	230,882	67,634	-105,942	19,162	-4,447	15,077	-23,398	-11,609	24,312	261,352
Creditors	-779,249	29,938	92,418	468,003	136,962	201,393	-875,410	858,557	2,953	-16,501	-17,908	-16,270	7,243	106,070
Accruals and Deferred Income	-433,110	-146,781	169,854	372,997	114,210	-185,958	290,090	-159,633	11,345	-260,219	277,954	-351,756	117,246	365,063
Deferred Taxes & Provisions		-3,750	807	-902	24,122		-14,141	14,141					-396	396
Cash flow from operations	-1,339,445	63,807	503,694	457,835	49,217	-6,963	-511,131	714,969	9,922	-216,381	308,312	-329,006	121,789	158,442
Investing Activities
capital expenditure	1,024,241	-40,873	-41,023	-1,138,171	-119,968	-74,940				-1,474	-1		-7,727	-7,594
Change in Investments
cash flow from investments	1,024,241	-40,873	-41,023	-1,138,171	-119,968	-74,940				-1,474	-1		-7,727	-7,594
Financing Activities
Bank loans
Group/Directors Accounts				-26,848	-2,533	29,381		-622,924	74,447	548,477	-398,362	398,362
Other Short Term Loans
Long term loans	-92,705	-96,390	-97,360	904,483
Hire Purchase and Lease Commitments
other long term liabilities
share issue			3,530	-3,530										191,980
interest	-68,100	-55,158	-58,993	-30,243	512	653	1,029	-44,092	-41,378	-29,729	-24,151	-25,116	-17,752	-9,128
cash flow from financing	-160,805	-151,548	-152,823	843,862	-2,021	30,034	1,029	-667,016	33,069	518,748	-422,513	373,246	-17,752	182,852
cash and cash equivalents
cash	-470,902	-178,615	363,149	255,854	-72,772	-51,870	-510,102	22,953	17,991	265,593	-114,202	44,240	96,310	333,700
overdraft	5,106	-50,000	53,300	92,328
change in cash	-476,008	-128,615	309,849	163,526	-72,772	-51,870	-510,102	22,953	17,991	265,593	-114,202	44,240	96,310	333,700

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for freeman,grieve limited. Get real-time insights into freeman,grieve limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for freeman,grieve limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HP7 area or any other competitors across 12 key performance metrics.

FREEMAN,GRIEVE LIMITED group structure

Freeman,Grieve Limited has no subsidiary companies.

Ultimate parent company

RADIANT MEDICARE LIMITED

06555203

RADIPHARM LIMITED

10308234

2 parents

FREEMAN,GRIEVE LIMITED

00370363

FREEMAN,GRIEVE LIMITED Shareholders

radipharm limited

100%

Freeman,Grieve Limited currently has 1 director, Mr Neal Radia serving since Jun 2017.

officer	country	age	start	end	role
Mr Neal Radia	England	41 years	Jun 2017	-	Director

P&L

April 2023

turnover

3.6m

-42%

operating profit

-5.6k

gross margin

32.8%

-2.19%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

900.8k

-0.08%

total assets

-0.4%

cash

1.3k

-1%

net assets

Total assets minus all liabilities

Similar Companies

cheadle pharma ltd

sabel chemist limited

sumer health limited

nemhill limited

shamiraj (chemists) limited

4.5

company number

00370363

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

October 1941

ultimate parent company

RADIANT MEDICARE LIMITED

previous names

N/A

address

2 burton house repton place,, white lion road, amersham, HP7 9LP

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 7 charges/mortgages relating to freeman,grieve limited. Currently there are 7 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for FREEMAN,GRIEVE LIMITED. This can take several minutes, an email will notify you when this has completed.

freeman,grieve limited Company Information

freeman,grieve limited Estimated Valuation

freeman,grieve limited Estimated Valuation

freeman,grieve limited Estimated Valuation

Freeman,grieve Limited Overview

Freeman,grieve Limited Health Check

FREEMAN,GRIEVE LIMITED financials

freeman,grieve limited Credit Report and Business Information

Freeman,grieve Limited Competitor Analysis

freeman,grieve limited Ownership

freeman,grieve limited directors

freeman,grieve limited company details

freeman,grieve limited Charges & Mortgages

freeman,grieve limited Capital Raised & Share Issues BETA

freeman,grieve limited Companies House Filings - See Documents